Pelvic Sentinel lymph node detection in High-Risk Endometrial Cancer (SHREC-trial)—the final step towards a paradigm shift in surgical staging

Jan Persson, Sahar Salehi, Michele Bollino, +3

European Journal of Cancer

Robot-assisted approach to cervical cancer (RACC): an international multi-center, open-label randomized controlled trial

Henrik Falconer, Kolbrún Pálsdóttir, Karin Stålberg, +10

International Journal of Gynecological Cancer

Robot-assisted laparoscopy versus laparotomy for infrarenal paraaortic lymphadenectomy in women with high-risk endometrial cancer: A randomised controlled trial

Sahar Salehi, Elisabeth Åvall‐Lundqvist, Berit Legerstam, +2

European Journal of Cancer

Infrarenal Paraaortic LymphadenectomyGynecologic SurgeryLaparoscopySurgical OncologyGynecological Surgery +8

The annual recurrence risk model for tailored surveillance strategy in patients with cervical cancer

David Cibula, Lukáš Dostálek, Jiří Jarkovský, +29

European Journal of Cancer

Cervical Cancer ManagementCervical Cancer ScreeningCancer EpidemiologyCervical HealthCervical Cancer +13

Ultra-radical upfront surgery does not improve survival in women with advanced epithelial ovarian cancer; a natural experiment in a complete population

Henrik Falconer, Ulrika Joneborg, Kamilla Krawiec, +3

Gynecologic Oncology

Reporting and incidence trends of hydatidiform mole in Sweden 1973–2004

Sahar Salehi, Sandra Eloranta, Anna L.V. Johansson, +2

Acta Oncologica

Intraperitoneal ropivacaine reduces time interval to initiation of chemotherapy after surgery for advanced ovarian cancer: randomised controlled double-blind pilot study

Jane Hayden, Jonatan Oras, Linda Block, +5

British Journal of Anaesthesia

Gynecologic SurgerySurgical OncologyAdvanced Ovarian CancerMedicinePostoperative Pain Management +12

Long-term quality of life after comprehensive surgical staging of high-risk endometrial cancer – results from the RASHEC trial

Sahar Salehi, Yvonne Brandberg, Elisabeth Åvall‐Lundqvist, +3

Acta Oncologica

The drug efficacy testing in 3D cultures platform identifies effective drugs for ovarian cancer patients

Emma Åkerlund, Greta Gudoitytė, Elisabeth Moussaud-Lamodière, +11

npj Precision Oncology

TRUST: Trial of radical upfront surgical therapy in advanced ovarian cancer (ENGOT ov33/AGO‐OVAR OP7).

Sven� Mahner, Florian Heitz, Sahar Salehi, +16

Journal of Clinical Oncology